Article Details
Retrieved on: 2021-07-01 14:41:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... it has signed an agreement to nonexclusively license its CRISPR-Cas9 patent portfolio to the Japanese biotechnology company Nippon Gene Co.
Article found on: www.genomeweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here